Altamira Therapeutics Ltd. sell shadow
Start price
10.03.21
/
0%
€3.98
Target price
10.03.22
-
Performance (%)
-74.62%
End price
11.03.22
€1.01
Summary
This prediction ended on 11.03.22 with a price of €1.01. The SELL prediction by shadow for Altamira Therapeutics Ltd. performed very well with a performance of -74.62%. This prediction was marked as speculative and is excluded from shadow's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Altamira Therapeutics Ltd. | - | - | - | - |
iShares Core DAX® | 2.149% | 5.415% | 21.385% | 22.595% |
iShares Nasdaq 100 | 0.838% | 1.926% | 44.386% | 55.330% |
iShares Nikkei 225® | 1.143% | 2.887% | 27.641% | 9.481% |
iShares S&P 500 | 1.265% | 3.698% | 33.327% | 49.646% |
According to shadow what are the pros and cons of Altamira Therapeutics Ltd. for the foreseeable future?
Pros
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Known brand
Capable Management
Cons
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
negative Cash Flow expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Bad culture
Little innovation
Few uniques
Significant cyclical dependencies
Business model of the past or high risk
High valuation
Below average Marketposition
Comments by shadow for this prediction
In the thread Altamira Therapeutics Ltd. diskutieren
Sell Auris Medical Holding AG
In the thread Trading Altamira Therapeutics Ltd.
Die von shadow gewählte maximale Laufzeit wurde überschritten